We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Select Pharmaceuticals Port Fund seeks capital appreciation by investing in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all kinds. FPHAX advisors also invest in common stocks.
Fidelity Select Pharmaceuticals Port Fund has three-year annualized returns of 6.8%. As of August 2023, FPHAX held 57 issues, with 21.3% of its assets invested in Eli Lilly and Co.
Janus Henderson Global Life Sciences Fund invests its net assets in securities issued by firms that the advisors believe have a life science emphasis. JNGLX has created a fundamental policy mandating a minimum investment of its total assets in securities issued by firms categorized under the "life sciences" sector.
Janus Henderson Global Life Sciences Fund has a three-year annualized return of 4%. Andy Acker has been the fund manager of JNGLX since April 2007.
Vanguard Health Care Fund seeks long-term growth of capital and dividend income. VGHCX invests in common stocks of companies in a variety of segments of the healthcare industry, which include pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals and other healthcare facilities, and biotechnological researchers.
Vanguard Health Care Fund has three-year annualized returns of 5.6%. VGHCX has an expense ratio of 0.36% compared with the category average of 1.03%.
Image: Bigstock
3 Healthcare Mutual Funds for a Robust Portfolio
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three healthcare mutual funds, viz Fidelity Select Pharmaceuticals Port Fund (FPHAX - Free Report) , Janus Henderson Global Life Sciences Fund (JNGLX - Free Report) and Vanguard Health Care Fund (VGHCX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Fidelity Select Pharmaceuticals Port Fund seeks capital appreciation by investing in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all kinds. FPHAX advisors also invest in common stocks.
Fidelity Select Pharmaceuticals Port Fund has three-year annualized returns of 6.8%. As of August 2023, FPHAX held 57 issues, with 21.3% of its assets invested in Eli Lilly and Co.
Janus Henderson Global Life Sciences Fund invests its net assets in securities issued by firms that the advisors believe have a life science emphasis. JNGLX has created a fundamental policy mandating a minimum investment of its total assets in securities issued by firms categorized under the "life sciences" sector.
Janus Henderson Global Life Sciences Fund has a three-year annualized return of 4%. Andy Acker has been the fund manager of JNGLX since April 2007.
Vanguard Health Care Fund seeks long-term growth of capital and dividend income. VGHCX invests in common stocks of companies in a variety of segments of the healthcare industry, which include pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals and other healthcare facilities, and biotechnological researchers.
Vanguard Health Care Fund has three-year annualized returns of 5.6%. VGHCX has an expense ratio of 0.36% compared with the category average of 1.03%.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>